Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry

INTRODUCTION: Despite the availability of multiple effective therapies, discontinuation/switching of treatment is common for many patients with rheumatoid arthritis (RA). This study was designed to examine initiation of biologic disease-modifying anti-rheumatic drugs (bDMARDs) within the Consortium...

Descripción completa

Detalles Bibliográficos
Autores principales: Strand, Vibeke, Miller, Paul, Williams, Setareh A., Saunders, Katherine, Grant, Shannon, Kremer, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696290/
https://www.ncbi.nlm.nih.gov/pubmed/28831751
http://dx.doi.org/10.1007/s40744-017-0078-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696290/
https://www.ncbi.nlm.nih.gov/pubmed/28831751
http://dx.doi.org/10.1007/s40744-017-0078-y

Ejemplares similares